• RE-RELEASE from Season 2: Mayo Clinic Talks "Evaluating Hematuria"

  • 2024/12/24
  • 再生時間: 19 分
  • ポッドキャスト

RE-RELEASE from Season 2: Mayo Clinic Talks "Evaluating Hematuria"

  • サマリー

  • Host: Darryl S. Chutka, M.D.

    Guest: Aaron M. Potretzke, M.D.

    Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!

    Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.

    Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

    続きを読む 一部表示

あらすじ・解説

Host: Darryl S. Chutka, M.D.

Guest: Aaron M. Potretzke, M.D.

Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!

Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

RE-RELEASE from Season 2: Mayo Clinic Talks "Evaluating Hematuria"に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。